Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fujingshu Tablets
- Development stage
- Unknown
- Lead developer
- Xi'an Tianrui Pharmaceutical Development
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Fujingshu Tablets is a Traditional Chinese Medicine (TCM) product developed by Xi'an Tianrui Pharmaceutical Development Co., Ltd. for the treatment of sequelae of chronic pelvic inflammatory disease (CPID). The formulation is designed to address the TCM syndrome of damp-heat and blood stasis, which is characterized by symptoms such as lower abdominal pain and increased vaginal discharge. In clinical studies, including a Phase 3 trial (CTR20150286), the efficacy and safety of the tablets were evaluated in Chinese women. The therapeutic approach involves clearing heat, detoxifying, and promoting blood circulation to resolve stasis and alleviate chronic inflammation in the pelvic cavity.
- Brand names
- Fujingshu Tablets
- Other names
- Fujingshu Pian
Beyond the preview
Go deeper on Fujingshu Tablets.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Fujingshu Tablets.